Disruptor-1, trial summary    PDF trial summary

A randomised clinical trial investigating the effect of BNC105P + everolimus versus everolimus in


Studied treatment
Control treatment

Group sizes-9 / -9
treatment line
cross over

Blindness Inclusion period
Follow-up duration Centers
Lost to FU geographical localisation
Primary endpoint Design

EndpointX1N1X0N0TE95% CI PFS - -9 - -9 no data OS - -9 - -9 no data0,22,01,0

Registering number (see trial on clinicaltrials.gov)
Code Name